Cargando…

Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study

RATIONALE: Studies have suggested mental health improvements following the use of the psychotropic plant concoction ayahuasca in non-clinical and clinical samples. OBJECTIVES: The present observational study assessed depressive symptomatology in 20 clinically depressed patients (symptom score > 1...

Descripción completa

Detalles Bibliográficos
Autores principales: van Oorsouw, Kim, Toennes, S. W., Ramaekers, J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785027/
https://www.ncbi.nlm.nih.gov/pubmed/35072760
http://dx.doi.org/10.1007/s00213-021-06046-9
_version_ 1784638872433459200
author van Oorsouw, Kim
Toennes, S. W.
Ramaekers, J. G.
author_facet van Oorsouw, Kim
Toennes, S. W.
Ramaekers, J. G.
author_sort van Oorsouw, Kim
collection PubMed
description RATIONALE: Studies have suggested mental health improvements following the use of the psychotropic plant concoction ayahuasca in non-clinical and clinical samples. OBJECTIVES: The present observational study assessed depressive symptomatology in 20 clinically depressed patients (symptom score > 13 on the Beck’s Depression Inventory) before attendance of an ayahuasca ceremony and 1 month and 1 year after. Secondary measures included ratings of altered states of consciousness and ego dissolution during the ayahuasca ceremony as well as global measures of mindfulness, satisfaction with life, depression, anxiety, and stress. RESULTS: Twenty participants completed baseline and 1-day follow-up, 19 completed measures at 1-month follow-up, and 17 completed measures at 1-year follow-up. BDI scores reduced from baseline (M = 22.7) to all post-ceremony measures (Ms 11.45, 12.89, and 8.88, for 1-day, 1-month, and 1-year follow-up, respectively). After 1 day, 12/20 participants were in remission (BDI < 13). Remission rates after 1 month and 1 year were 13/19 and 12/17, respectively. Three participants remained mildly depressed (BDI 14–19) at the 1-month and 1-year follow-up. Two participants did not respond and remained at a moderate/severe level of depression at 1-year follow-up. Reductions on the secondary mental health measures and increases in mindfulness and satisfaction with life were found up to 1 year post-ceremony. Improvements in clinical depression and mental health correlated with levels of experienced ego dissolution and oceanic boundlessness during the ceremony up to 1 month after the ceremony. Engagement in additional mental health treatments or use of another psychedelic during study participation may have contributed to improved mental health ratings at 1-year follow-up. CONCLUSION: Ayahuasca produces long-term mental health improvements in clinically depressed patients, which highlights its therapeutic potential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00213-021-06046-9.
format Online
Article
Text
id pubmed-8785027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87850272022-01-24 Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study van Oorsouw, Kim Toennes, S. W. Ramaekers, J. G. Psychopharmacology (Berl) Original Investigation RATIONALE: Studies have suggested mental health improvements following the use of the psychotropic plant concoction ayahuasca in non-clinical and clinical samples. OBJECTIVES: The present observational study assessed depressive symptomatology in 20 clinically depressed patients (symptom score > 13 on the Beck’s Depression Inventory) before attendance of an ayahuasca ceremony and 1 month and 1 year after. Secondary measures included ratings of altered states of consciousness and ego dissolution during the ayahuasca ceremony as well as global measures of mindfulness, satisfaction with life, depression, anxiety, and stress. RESULTS: Twenty participants completed baseline and 1-day follow-up, 19 completed measures at 1-month follow-up, and 17 completed measures at 1-year follow-up. BDI scores reduced from baseline (M = 22.7) to all post-ceremony measures (Ms 11.45, 12.89, and 8.88, for 1-day, 1-month, and 1-year follow-up, respectively). After 1 day, 12/20 participants were in remission (BDI < 13). Remission rates after 1 month and 1 year were 13/19 and 12/17, respectively. Three participants remained mildly depressed (BDI 14–19) at the 1-month and 1-year follow-up. Two participants did not respond and remained at a moderate/severe level of depression at 1-year follow-up. Reductions on the secondary mental health measures and increases in mindfulness and satisfaction with life were found up to 1 year post-ceremony. Improvements in clinical depression and mental health correlated with levels of experienced ego dissolution and oceanic boundlessness during the ceremony up to 1 month after the ceremony. Engagement in additional mental health treatments or use of another psychedelic during study participation may have contributed to improved mental health ratings at 1-year follow-up. CONCLUSION: Ayahuasca produces long-term mental health improvements in clinically depressed patients, which highlights its therapeutic potential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00213-021-06046-9. Springer Berlin Heidelberg 2022-01-24 2022 /pmc/articles/PMC8785027/ /pubmed/35072760 http://dx.doi.org/10.1007/s00213-021-06046-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Investigation
van Oorsouw, Kim
Toennes, S. W.
Ramaekers, J. G.
Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
title Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
title_full Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
title_fullStr Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
title_full_unstemmed Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
title_short Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
title_sort therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785027/
https://www.ncbi.nlm.nih.gov/pubmed/35072760
http://dx.doi.org/10.1007/s00213-021-06046-9
work_keys_str_mv AT vanoorsouwkim therapeuticeffectofanayahuascaanalogueinclinicallydepressedpatientsalongitudinalobservationalstudy
AT toennessw therapeuticeffectofanayahuascaanalogueinclinicallydepressedpatientsalongitudinalobservationalstudy
AT ramaekersjg therapeuticeffectofanayahuascaanalogueinclinicallydepressedpatientsalongitudinalobservationalstudy